1260671-35-9 Usage
General Description
1H-Pyrrolo[3,2-b]pyridine, 5-bromo-2,3-dihydro- is a chemical compound with the molecular formula C8H6BrN. It is a heterocyclic compound with a pyrrolopyridine backbone and a bromine substituent at position 5. 1H-Pyrrolo[3,2-b]pyridine, 5-bromo-2,3-dihydro- is a key building block in the synthesis of various pharmaceuticals and bioactive compounds. It has been used in the development of potential anticancer and antiviral agents, as well as in the study of biological processes and drug discovery. 1H-Pyrrolo[3,2-b]pyridine, 5-bromo-2,3-dihydro- is also known for its potential as a synthetic intermediate in organic chemistry and medicinal chemistry research.
Check Digit Verification of cas no
The CAS Registry Mumber 1260671-35-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,0,6,7 and 1 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1260671-35:
(9*1)+(8*2)+(7*6)+(6*0)+(5*6)+(4*7)+(3*1)+(2*3)+(1*5)=139
139 % 10 = 9
So 1260671-35-9 is a valid CAS Registry Number.
1260671-35-9Relevant articles and documents
CANCER TREATMENTS TARGETING CANCER STEM CELLS
-
Paragraph 0331; 0554; 0561-0562, (2019/11/19)
Disclosed are compounds, methods, compositions, and kits that allow for treating cancer by, e.g., targeting cancer stem cells. In some embodiments, the cancer is colorectal cancer, gastric cancer, gastrointestinal stromal tumor, ovarian cancer, lung cancer, breast cancer, pancreatic cancer, prostate cancer, testicular cancer, or lymphoma. In some embodiments, the cancer is liver cancer, endometrial cancer, leukemia, or multiple myeloma. The compounds utilized in the disclosure are of Formula (0), (O'), and (I):
